| Tumor-priming smoothened inhibitor enhances deposition and efficacy of cytotoxic nanoparticles in a pancreatic cancer model T Roy Chaudhuri, NL Straubinger, RF Pitoniak, BL Hylander, EA Repasky, ... Molecular cancer therapeutics 15 (1), 84-93, 2016 | 41 | 2016 |
| Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation T Roy Chaudhuri, RD Arnold, J Yang, SG Turowski, Y Qu, JA Spernyak, ... Pharmaceutical research 29, 3312-3324, 2012 | 17 | 2012 |
| Nanoparticles for Brain Tumor Delivery TR Chaudhuri, RM Straubinger Nervous System Drug Delivery, 229-250, 2019 | 10 | 2019 |
| Formation of hydrated PEG layers on magnetic iron oxide nanoflowers shows internal magnetisation dynamics and generates high in-vivo efficacy for MRI and magnetic hyperthermia EP McKiernan, C Moloney, TR Chaudhuri, S Clerkin, K Behan, ... Acta biomaterialia 152, 393-405, 2022 | 9 | 2022 |
| Methyl dynamics for understanding hydrophobic core packing of dynamically different motifs of double‐stranded RNA binding domain of protein kinase R RP Barnwal, TR Chaudhuri, S Nanduri, J Qin, KVR Chary Proteins: Structure, Function, and Bioinformatics 62 (2), 501-508, 2006 | 6 | 2006 |
| Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition C Moloney, TR Chaudhuri, JA Spernyak, RM Straubinger, DF Brougham Acta biomaterialia 158, 611-624, 2023 | 4 | 2023 |
| Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer Q Lin, A Serratore, J Perri, T Roy Chaudhuri, J Qu, WW Ma, ES Kandel, ... British Journal of Pharmacology 181 (9), 1383-1403, 2024 | 3 | 2024 |
| Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors T Roy Chaudhuri, Q Lin, EK Stachowiak, SR Rosario, JA Spernyak, ... Clinical Cancer Research, OF1-OF15, 2024 | 1 | 2024 |
| FGFR inhibitors enhance gemcitabine sensitivity in pancreatic ductal adenocarcinoma Q Lin, TR Chaudhuri, NL Straubinger, WW Ma, RM Straubinger Cancer Research 77 (13_Supplement), 4072-4072, 2017 | 1 | 2017 |
| Activity of an EphA2‐targeted docetaxel nanoliposome in pancreatic patient‐derived models as monotherapy and in combination with gemcitabine DC Drummond, NL Straubinger, TR Chaudhuri, M Moser, WS Kamoun, ... Cancer Research 76 (14 Suppl), 2069, 2016 | 1 | 2016 |
| Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness Q Lin, A Serratore, J Niu, S Shen, TR Chaudhuri, WW Ma, J Qu, ... Drug Resistance Updates 73, 101064, 2024 | | 2024 |
| Role of Fibroblasts in Epithelial to Mesenchymal Transition via Sonic Hedgehog Pathway in Co-culture Model of Pancreatic Ductal Adenocarcinoma N Haldankar State University of New York at Buffalo, 2020 | | 2020 |
| FGFR1 inhibitor reverses Smoothened inhibition-induced epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma TR Chaudhuri, Q Lin, NL Straubinger, WW Ma, RM Straubinger Cancer Research 77 (13_Supplement), 4071-4071, 2017 | | 2017 |
| Effects of sonic Hedgehog inhibitor combined with nanoparticulate drug delivery on vascular permeability and efficacy in a pancreatic cancer model TR Chaudhuri, NL Straubinger, R Pitoniak, BL Hylander, WJ Jusko, ... Cancer Research 72 (8_Supplement), 5685-5685, 2012 | | 2012 |
| Strategies for improving chemotherapeutic delivery to solid tumors mediated by vascular permeability modulation TR Chaudhuri State University of New York at Buffalo, 2012 | | 2012 |
| NERVOUS SYSTEM DRUG DELIVERY RR LONSER, M SARNTINORANONT | | |
Robert M. StraubingerProfessor of Pharmaceutical Sciences, University of Buffalo, State University of New YorkVerifierad e-postadress på buffalo.edu
